Eric E. Poma, CEO of Calidi Biotherapeutics ($CLDI), made one open market purchase of company shares worth $50,000 in the last year, with the latest on August 21, 2025. This ranks him 2,996th among 4,983 insiders by purchase value, well below the average of $1.46 million across 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Poma Eric E | Chief Executive Officer | A | Stock Options (right to buy) | 10000 | $0.00 | 10,000.0000 | 28,467,580 | 9999.99% | 0.04% |
| Aug. 21, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Poma Eric E | Chief Executive Officer | P | Common Stock | 25000 | $2.00 | 25,000.0000 | 28,467,580 | 9999.99% | 0.09% |
| Aug. 21, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Poma Eric E | Chief Executive Officer | P | Warrant (right to buy) | 25000 | $0.00 | 25,000.0000 | 28,467,580 | 9999.99% | 0.09% |
| April 22, 2025 | Calidi Biotherapeutics, Inc. | $CLDI | Poma Eric E | Chief Executive Officer | A | Stock Option (right to buy) | 726412 | $0.00 | 726,412.0000 | 28,467,580 | 9999.99% | 2.55% |